Search Results - "KYRLE, P."

Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH by Kearon, C., Ageno, W., Cannegieter, S. C., Cosmi, B., Geersing, G.‐J., Kyrle, P. A.

Get full text

Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH by Dronkers, C. E. A., Hulle, T., Le Gal, G., Kyrle, P. A., Huisman, M. V., Cannegieter, S. C., Klok, F. A.

Get full text

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis by BAGLIN, T., DOUKETIS, J., TOSETTO, A., MARCUCCI, M., CUSHMAN, M., KYRLE, P., PALARETI, G., POLI, D., TAIT, R. C., IORIO, A.

“…Aim: To determine if the mode of presentation of venous thromboembolism (VTE), as deep vein thrombosis (DVT) or pulmonary embolism (PE), predicts the…”
Get full text

The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study by Eischer, L., Eichinger, S., Kyrle, P. A.

“…Summary Background The optimal duration of anticoagulation for women who had venous thromboembolism (VTE) associated with estrogen use is unknown. Objectives…”
Get full text

The long‐term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study by Kyrle, P. A., Kammer, M., Eischer, L., Weltermann, A., Minar, E., Hirschl, M., Heinze, G., Eichinger, S.

“…Essentials Long‐term recurrence risk of venous thromboembolism (VTE) is uncertain. We performed a prospective cohort study of 839 patients with first…”
Get full text

Natural antibodies to oxidation‐specific epitopes: innate immune response and venous thromboembolic disease by Eichinger, S., Kyrle, P.A., Kammer, M., Eischer, L., Ozsvar Kozma, M., Binder, C. J.

“…Essentials Natural antibodies to oxidation‐specific epitopes have antithrombotic properties. We evaluated the relation between natural IgM and IgG antibodies…”
Get full text

Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects by Traby, L., Kollars, M., Kaider, A., Eichinger, S., Wolzt, M., Kyrle, P. A.

“…Essentials In acute coronary syndromes, dual antiplatelet therapy inhibits platelets but confers a bleeding risk. Healthy male volunteers received clopidogrel…”
Get full text

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB) by Gebhart, J., Hofer, S., Panzer, S., Quehenberger, P., Sunder‐Plassmann, R., Hoermann, G., Eigenbauer, E., Haslacher, H., Kepa, S., Kyrle, P. A., Eichinger, S., Knöbl, P., Eischer, L., Mannhalter, C., Ay, C., Pabinger, I.

“…Introduction Data on clinical characteristics and the prevalence of underlying coagulopathies in patients with mild‐to‐moderate bleeding disorders (MBDs) are…”
Get full text

The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease by STAIN, M., SCHÖNAUER, V., MINAR, E., BIALONCZYK, C., HIRSCHL, M., WELTERMANN, A., KYRLE, P. A., EICHINGER, S.

“…Background: The post‐thrombotic syndrome (PTS) is a frequent complication of deep vein thrombosis (DVT). Patients with recurrent ipsilateral DVT have an…”
Get full text

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data by Marcucci, M., Iorio, A., Douketis, J. D., Eichinger, S., Tosetto, A., Baglin, T., Cushman, M., Palareti, G., Poli, D., Tait, R. C., Kyrle, P. A.

“…Summary Background In order to stratify patients with a first unprovoked venous thromboembolism (VTE) according to their recurrence risk and to identify those…”
Get full text

Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis by PABINGER, I., GRAFENHOFER, H., KAIDER, A., KYRLE, P. A., QUEHENBERGER, P., MANNHALTER, C., LECHNER, K.

“…Background: Limited data exist on the risk of pregnancy‐associated venous thromboembolism (VTE) in women with a history of VTE. Objective: To evaluate the risk…”
Get full text

Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH by Dronkers, C. E. A., Ende‐Verhaar, Y. M., Kyrle, P. A., Righini, M., Cannegieter, S. C., Huisman, M. V., Klok, F. A.

Get full text

Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study by Eischer, L., Kammer, M., Traby, L., Kyrle, P. A., Eichinger, S.

“…Essentials Data on long‐term cancer risk are controversial in patients with venous thromboembolism (VTE). We assessed long‐term rates and risk factors of…”
Get full text

Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial by Traby, L., Kaider, A., Kollars, M., Eichinger, S., Wolzt, M., Kyrle, P.A.

“…Dual-antiplatelet therapy (DAPT) is a standard strategy in acute coronary heart disease; however, it confers a considerable bleeding risk. Single-antiplatelet…”
Get full text

von Willebrand factor-factor VIII concentrate (Haemate super( registered ) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery by Lethagen, S, Kyrle, P A, Castaman, G, Haertel, S, Mannucci, P M

“…Background: While plasma-derived concentrates containing large amounts of von Willebrand factor (VWF) are effective in treating von Willebrand disease (VWD),…”
Get full text

High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism by Kyrle, Paul A, Minar, Erich, Hirschl, Mirko, Bialonczyk, Christine, Stain, Milena, Schneider, Barbara, Weltermann, Ansgar, Speiser, Wolfgang, Lechner, Klaus, Eichinger, Sabine

“…Elevated plasma levels of factor VIII are associated with an increased risk of venous thrombosis. 1 – 3 In the Leiden Thrombophilia Study, plasma levels of…”
Get full text

Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts by Roach, R. E. J., Lijfering, W. M., Tait, R.C., Baglin, T., Kyrle, P. A., Cannegieter, S. C., Rosendaal, F. R.

“…Summary Background Previous analyses reported a higher risk of recurrent venous thrombosis in men than women. Objectives We aimed to assess the risk of…”
Get full text

Chemotherapy‐induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity by LECHNER, D., KOLLARS, M., GLEISS, A., KYRLE, P. A., WELTERMANN, A.

“…Background: Cisplatin‐based chemotherapy predisposes cancer patients to thromboembolic events. Objectives: To investigate whether endothelial damage, via…”
Get full text

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis by Douketis, James, Tosetto, Alberto, Marcucci, Maura, Baglin, Trevor, Cosmi, Benilde, Cushman, Mary, Kyrle, Paul, Poli, Daniela, Tait, R Campbell, Iorio, Alfonso

“…Objective To determine the effect of sex on the risk of recurrent venous thromboembolism in all patients and in patients with venous thromboembolism that was…”
Get full text

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome by Furlan, Miha, Robles, Rodolfo, Galbusera, Miriam, Remuzzi, Giuseppe, Kyrle, Paul A, Brenner, Brigitte, Krause, Manuela, Scharrer, Inge, Aumann, Volker, Mittler, Uwe, Solenthaler, Max, Lämmle, Bernhard

“…Thrombotic thrombocytopenic purpura, a disseminated thrombotic microangiopathy, was initially described by Moschcowitz in 1924. 1 Three decades later, Gasser…”
Get full text